KCM

Knoll Capital Management Portfolio holdings

AUM $141M
This Quarter Return
+74.49%
1 Year Return
+51.8%
3 Year Return
+256.4%
5 Year Return
+482.18%
10 Year Return
+5,137.57%
AUM
$117M
AUM Growth
+$117M
Cap. Flow
+$2.65M
Cap. Flow %
2.27%
Top 10 Hldgs %
97.29%
Holding
16
New
1
Increased
1
Reduced
2
Closed

Sector Composition

1 Healthcare 99.84%
Name Market Value Portfolio Weight Shares or Principal Shares
Change %
Capital Flow
ABEO icon
1
Abeona Therapeutics
ABEO
$350M
$40.2M 34.4% 2,359,767
BHVN
2
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
$30.2M 25.78% 807,224
CRBP icon
3
Corbus Pharmaceuticals
CRBP
$115M
$26.7M 22.86% 3,738,925
NTBL
4
DELISTED
Notable Labs, Ltd. Ordinary Shares
NTBL
$5.25M 4.49% 860,605
AVXL icon
5
Anavex Life Sciences
AVXL
$828M
$3M 2.56% 724,205
KRYS icon
6
Krystal Biotech
KRYS
$4.27B
$2.99M 2.56% +300,000 New +$2.99M
AMPE
7
DELISTED
Ampio Pharmaceuticals Inc.
AMPE
$1.61M 1.38% 2,595,484
KERX
8
DELISTED
Keryx Biopharmaceuticals Inc
KERX
$1.42M 1.21% 200,000
VNRX icon
9
VolitionRX
VNRX
$74.2M
$1.24M 1.06% 461,538
SMMT icon
10
Summit Therapeutics
SMMT
$17.6B
$1.15M 0.99% 91,800 -8,200 -8% -$103K
ALDX icon
11
Aldeyra Therapeutics
ALDX
$351M
$893K 0.76% 124,096
ARCT icon
12
Arcturus Therapeutics
ARCT
$462M
$812K 0.69% 804,049 -401,449 -33% -$405K
EVOK icon
13
Evoke Pharma
EVOK
$8.49M
$752K 0.64% 225,000 +50,000 +29% +$167K
LSTA icon
14
Lisata Therapeutics
LSTA
$19.9M
$422K 0.36% 117,957
ADXSW
15
DELISTED
Advaxis, Inc. Warrants
ADXSW
$191K 0.16% 112,500
LPCN icon
16
Lipocine
LPCN
$15.8M
$99K 0.08% 25,000